Preferred Label : risks and benefits;
UMLS semantic type : T080 - Qualitative Concept;
Origin ID : M0408370;
UMLS CUI : C0687742;
Related record
- Semantic type(s)
https://www.cochrane.org/fr/CD015005/CENTRALED_quels-sont-les-benefices-et-les-risques-de-lazathioprine-un-type-de-medicament-qui-affecte-la
2025
United Kingdom
review of literature
french abstract
organ part
Organisms Category
azathioprine
disease
risks and benefits
organizations
disease, nos
drug, nos
affect, nos
multiple sclerosis
risk assessment
affect
pharmaceutical preparations
immune response, nos
persons
azathioprine
multiple sclerosis, nos
multiple sclerosis
---
https://www.cochrane.org/fr/CD015551/CENTRALED_quels-sont-les-benefices-et-risques-des-vaccins-pour-la-prevention-des-maladies-infectieuses-chez
2025
United Kingdom
review of literature
french abstract
vaccinia, nos
infection control
disease
communicable diseases
vaccine, nos
cancer
vaccination, nos
preventive immunization/medication
infectious disease, nos
vaccines
risks and benefits
adult disease, nos
neoplasm, malignant
vaccination
infectious diseases
risk assessment
adult
neoplasms
---
https://www.cochrane.org/fr/CD014937/RENAL_quels-sont-les-benefices-et-les-risques-des-diuretiques-pour-prevenir-ou-traiter-latteinte-renale
2025
United Kingdom
review of literature
french abstract
risk assessment
diuretic, nos
risks and benefits
attentiveness
kidney, nos
diuretics
acute kidney injury
---
https://www.cochrane.org/fr/CD016119/CENTRALED_quels-sont-les-benefices-et-les-risques-de-la-myomectomie-pendant-une-cesarienne-chez-les-femmes
2025
United Kingdom
review of literature
french abstract
Myomectomy
leiomyoma
pregnancy, nos
fibromyoma uterus
leiomyoma, nos
Pregnant People
uterine myomectomy
risk assessment
risks and benefits
cesarean section, nos
fibroid uterus
uterine myomectomy, nos
cesarean section
---
https://www.cochrane.org/fr/CD013614/CENTRALED_quels-sont-les-benefices-et-risques-des-inhibiteurs-du-tnf-chez-les-personnes-atteintes-de
2025
United Kingdom
review of literature
french abstract
psoriasis, nos
arthritis
disease
risk assessment
polyarthritis
Polyarthritis
psoriasis
risks and benefits
tumor necrosis factor
persons
Tumor Necrosis Factor Inhibitors
anti-TNF
---
https://www.cochrane.org/fr/CD013715/CENTRALED_quels-sont-les-benefices-et-les-risques-des-inhibiteurs-du-facteur-de-necrose-tumorale-pour
2025
United Kingdom
review of literature
french abstract
rheumatoid arthritis, systemic juvenile
risk factors
arthritis, nos
unknown (origin)
risk factor
arthritis, juvenile
Tumor Necrosis Factor Inhibitors
risk assessment
risks and benefits
tumor necrosis factor
---
https://www.cochrane.org/fr/CD013745/CENTRALED_quels-sont-les-benefices-et-risques-des-anticoagulants-oraux-directs-aod-les-anticoagulants-de
2025
United Kingdom
review of literature
french abstract
Transcatheter Aortic Valve Replacement
anticoagulant, nos
leadership
aortic valve
risk assessment
replacement of catheter
guideline
risks and benefits
generations
anticoagulants
aorta, nos
oral anticoagulants
family characteristics
---
https://www.cochrane.org/fr/CD016168/CENTRALED_quels-sont-les-benefices-et-risques-des-transfusions-de-sang-et-de-produits-sanguins-pour-la-prise
2025
United Kingdom
review of literature
french abstract
blood
risk assessment
blood transfusion
postpartum hemorrhage
risks and benefits
hemorrhage
transfusion, nos
postpartum hemorrhage, nos
blood specimen collection
patient care management
risk-taking
---
https://www.cochrane.org/fr/CD015083/CENTRALED_quels-sont-les-benefices-et-risques-des-modeles-alternatifs-de-prestation-de-soins-pour-les
2025
United Kingdom
review of literature
french abstract
lumbago
nursing
low back pain
delivery of health care
risk assessment
persons
proportional hazards models
hazards models
risks and benefits
---
https://www.cochrane.org/fr/CD013429/CENTRALED_quels-sont-les-benefices-et-les-risques-de-la-dilatation-de-la-trompe-deustache-par-ballonnet-pour
2025
United Kingdom
review of literature
french abstract
risk assessment
risks and benefits
dysfunction of eustachian tube
dilatation, nos
eustachian tube
dilatation
obstruction of eustachian tube, nos
---
https://www.cochrane.org/fr/CD006027/CENTRALED_quels-sont-les-benefices-et-risques-des-anti-inflammatoires-non-steroidiens-ains-pour-le-traitement
2025
United Kingdom
review of literature
french abstract
non-steroidal anti-inflammatory agent, nos
renal colic
risk assessment
colic
kidney, nos
risks and benefits
anti-inflammatory agents, non-steroidal
abdominal colic
---
https://www.cochrane.org/fr/CD013342/CENTRALED_quels-sont-les-benefices-et-les-risques-des-injections-de-cellules-souches-pour-larthrose-du-genou
2025
United Kingdom
review of literature
french abstract
degenerative joint disease of lower leg
risk assessment
injection of knee, nos
risks and benefits
stem cell
osteoarthritis
osteoarthritis, knee
knee
injections
stem cells
---
https://www.cochrane.org/fr/CD014691/CENTRALED_quels-sont-les-benefices-et-les-risques-probables-des-traitements-non-medicaux-et-non-chirurgicaux
2025
United Kingdom
review of literature
french abstract
risks and benefits
risk assessment
low back pain
lumbago
non-specific
---
https://www.cochrane.org/fr/CD015749/CENTRALED_quels-sont-les-benefices-et-les-risques-lies-lutilisation-dune-combinaison-de-traitements-pour-gerer
2025
United Kingdom
review of literature
french abstract
disease
disease, nos
weight loss
risks and benefits
cachexia
decreased body weight
combined
risk assessment
cachexia, nos
---
https://www.cochrane.org/fr/CD012532/CENTRALED_quels-sont-les-benefices-et-les-risques-des-differents-medicaments-dimmunotherapie-pour-traiter-le
2025
United Kingdom
review of literature
french abstract
drug therapy
risk assessment
brain neoplasms
drug, nos
immunotherapy
risks and benefits
immunotherapy, nos
glioblastoma
glioblastoma, nos
---
https://www.cbip.be/fr/articles/4238?folia=4237
2024
false
false
false
Belgium
French
journal article
obesity
treatment outcome
semaglutide
risks and benefits
Benefit-Risk assessment
cardiovascular diseases
---
https://www.cochrane.org/fr/CD015432/SYMPT_quels-sont-les-benefices-et-les-risques-de-libuprofene-dans-la-prise-en-charge-de-la-douleur-apres
2024
United Kingdom
review of literature
french abstract
pain
child, nos
Pain Therapy
During or After
Status Post
ibuprofen
pain management
risks and benefits
Surgical Procedure
pain, nos
operative procedure, nos
child
What Month is it
Child Relation
surgical procedures, operative
Ibuprofen
risk-taking
risk assessment
Operation
ibuprofen
Child Individual
---
https://www.cochrane.org/fr/CD014687/NEUROMUSC_quels-sont-les-benefices-et-les-risques-des-traitements-non-chirurgicaux-et-chirurgicaux-du-nevrome
2024
United Kingdom
review of literature
french abstract
Non-Surgical
Usually Need Help from Another Person for Walking
Hard to Walk More Than One Block
Walking
Morton Neuroma
Morton Neuroma
Symptoms Interfered with Walking
pain, nos
walking
gait, nos
risk assessment
Forward
Raw
morton's metatarsalgia
Treatment Benefit
risks and benefits
What Month is it
ball of foot
Foot Pain
pain
---
https://www.cochrane.org/fr/CD014544/CF_quels-sont-les-benefices-et-les-risques-des-nouveaux-traitements-par-facteurs-non-coagulants-pour-la
2024
United Kingdom
review of literature
french abstract
risk factors
blood coagulation factors
hemophilia B
bloodletting
coagulants
Treatment Benefit
Feeding
Breeding
Risk Factor
Coagulation Factor
hemophilia b, nos
persons
risks and benefits
risk factor
F9 wt Allele
Feeding Ability
Prevention Study
Hemophilia B
What Month is it
disease
Raw
coagulation factor, nos
Hemorrhage
Preventive Intervention
risk assessment
bleeding precautions
hemorrhage
People
New Lesion Identification
Newar Language
preventive treatment, nos
---
https://www.cochrane.org/fr/CD015014/COLOCA_quels-sont-les-benefices-et-les-risques-de-loperation-roux-en-y-non-coupee-apres-ablation-de-la
2024
United Kingdom
review of literature
french abstract
risk assessment
Murine Stomach
NT5E wt Allele
neoplasm, malignant
Non-Surgical
Stomach
excision, nos
stomach, nos
malignant neoplasm stomach
stomach neoplasms
Raw
Cancer Therapeutic Procedure
operative procedure, nos
risks and benefits
stomach
Entity Name Data Type
cancer of stomach
surgical procedures, operative
Beyond
What Month is it
Post-Therapy
Ablation Therapy
---
https://www.cochrane.org/fr/CD003331/VASC_quels-sont-les-benefices-et-les-risques-de-la-readaptation-cardiaque-basee-sur-lexercice-pour
2024
United Kingdom
review of literature
french abstract
Cardiac Rehabilitation
risks and benefits
Heart Failure
exercise
heart failure, nos
What Month is it
risk assessment
post-cardiac rehabilitation training
Before Exercise
Exercise
Exercise Pain Management
Cardiac Rehabilitation
heart failure
---
https://www.cochrane.org/fr/CD013271/NEONATAL_quels-sont-les-benefices-et-les-risques-du-traitement-par-corticosteroides-des-prematures-presentant
2024
United Kingdom
review of literature
french abstract
adrenal cortical hormone, nos
Premature Infant
Bronchopulmonary Dysplasia
risk assessment
immature
What Month is it
Corticosteroid
adrenal cortex hormones
Too Early
Preterm Birth
bronchopulmonary dysplasia
infant, premature
corticosteroid therapy
risk
Treatment Benefit
risks and benefits
bronchopulmonary dysplasia of newborn
---
https://www.cochrane.org/fr/CD015112/OCCHEALTH_quels-sont-les-benefices-et-les-risques-des-interventions-sur-le-lieu-de-travail-visant-reduire-le
2024
United Kingdom
review of literature
french abstract
SARS Coronavirus
health
Worksite
hazardous substances
Sector
Adverse Event Associated with Infection
workplace
risks and benefits
potential for infection
What Month is it
risk assessment
risk
Infection
SARS-CoV-2
occupation, nos
---
https://www.cochrane.org/fr/CD010333/NEONATAL_quels-sont-les-benefices-et-les-risques-de-la-gestion-du-bruit-ou-du-son-dans-lunite-de-soins
2024
United Kingdom
review of literature
french abstract
Newborn
risks and benefits
Premature Infant
managed care programs
infant, low birth weight
Management Occupations
Intensive Care Unit Stay
immature
low birth weight
risk management
Too Early
Intensive Care Unit
infant
birth weight
Preterm Birth
noise
What Month is it
intensive care units, neonatal
risk assessment
premature birth
light-for-dates without mention of fetal malnutrition
Very Low Birth Weight
Management
Bruise
bruit
---
https://www.cochrane.org/fr/CD013414/RENAL_quels-sont-les-benefices-et-les-risques-de-lutilisation-de-la-metformine-dans-le-traitement-de-la
2024
United Kingdom
review of literature
french abstract
Metformin
renal insufficiency, chronic
kidney diseases
chronic disease
chronic disease, nos
Use
Chronic Kidney Disease, CTCAE
risk assessment
metformin
risks and benefits
Treatment Benefit
What Month is it
Chronic Renal Failure
kidney disease, nos
---
https://www.cochrane.org/fr/CD013366/PVD_quels-sont-les-benefices-et-les-risques-des-innovations-concernant-les-materiaux-et-la-conception
2024
United Kingdom
review of literature
french abstract
infectious disease, nos
risk assessment
lifting
Reprint Carrier
risks and benefits
Genetic Carrier
GDC Therapeutic Agent Terminology
Plastic
blood
Tube Dosing Unit
CDISC SEND Study Design Terminology
plastics
complication, nos
veins
Catheterization
Transportation
conception
conception
Infections
Infection
Pharmacologic Substance
carrying
transportation
Transport Device
drug, nos
Design
pharmaceutical preparations
Transfer
catheters
Blood
Carrying
Carrier Device
Blood Sample
fertilization
Complication
Conception
Medication
Conception Age
Murine Blood
equipment safety
Transport Process
plastic tube
Delivery
---
https://www.cochrane.org/fr/CD014869/LIVER_quels-sont-les-benefices-et-les-risques-du-tamoxifene-dans-le-traitement-des-personnes-atteintes-dun
2024
United Kingdom
review of literature
french abstract
disease
tamoxifen
persons
carcinoma, hepatocellular
risk assessment
tamoxifen
hepatocellular carcinoma, nos
risks and benefits
disease of liver, nos
---
https://www.cochrane.org/fr/CD015443/MS_quels-sont-les-benefices-et-les-risques-des-differents-traitements-susceptibles-de-retarder-ou-de
2024
United Kingdom
review of literature
french abstract
multiple sclerosis
multiple sclerosis, nos
Treatment Delay
risk assessment
multiple sclerosis
risks and benefits
---
https://www.cochrane.org/fr/CD015751/EYES_quels-sont-les-benefices-et-les-risques-des-collyres-lubrifiants-en-cas-dinconfort-lie-aux-lentilles
2024
United Kingdom
review of literature
french abstract
risk assessment
Lubricant Eye Drops
risks and benefits
malaise
snacks
lubricants
contact lenses
eyedrops
---
https://www.cochrane.org/fr/CD012850/ORAL_quels-sont-les-benefices-et-les-risques-dun-traitement-occlusal-chez-les-personnes-souffrant-de
2024
United Kingdom
review of literature
french abstract
joints
mandible, nos
articulators
temporomandibular joint disorders
risks and benefits
persons
jaw
risk assessment
---
https://www.cochrane.org/fr/CD014755/CENTRALED_quels-sont-les-benefices-et-les-risques-dune-chirurgie-preservant-la-fertilite-pour-traiter-une
2024
United Kingdom
review of literature
french abstract
asthenia
operative procedure, nos
body parts
systolic pressure
general surgery
fertility, nos
condom
risks and benefits
fertility preservation
trophoblasts
gestational trophoblastic disease
human body
risk
due to
risk assessment
---
https://www.cochrane.org/fr/CD011800/ENDOC_quels-sont-les-benefices-et-les-risques-dune-supplementation-en-vitamine-d-pour-les-adultes
2024
United Kingdom
review of literature
french abstract
operative procedure, nos
risks and benefits
3-dehydroretinol
risk assessment
weight loss
adult
weight loss
vitamins
adult-onset obesity
obesity
obesity
vitamin, nos
decreased body weight
alteration in nutrition: potential for more than body requirements
bariatric surgery
---
https://www.cochrane.org/fr/CD014688/CENTRALED_quels-sont-les-benefices-et-les-risques-de-lorientation-des-patients-pour-les-enfants-et-les
2024
United Kingdom
review of literature
french abstract
orientation
child
risks and benefits
chronically ill
chronic disease, nos
disease
adolescence
patients
chronic disease
adolescent
child, nos
patient referral, nos
risk assessment
---
https://www.cochrane.org/fr/CD016147/CENTRALED_quels-sont-les-benefices-et-les-risques-des-medicaments-contre-la-retention-du-placenta-apres-un
2024
United Kingdom
review of literature
french abstract
parturition
placenta
parturition, nos
placentation
retention, nos
risks and benefits
drug, nos
pharmaceutical preparations
placenta, retained
risk assessment
---
https://minerva-ebp.be/FR/Article/2404
2024
Belgium
critical appraisal or critical reading
Network Meta-Analysis as Topic
risks and benefits
drug therapy
diabetes non-insulin dependent
Outcome Assessment, Health Care
drug, nos
hypoglycemic agents
risk assessment
diabetes mellitus, type 2
resulting in
---
https://www.cochrane.org/fr/CD016148/CENTRALED_quels-sont-les-benefices-et-les-risques-des-differentes-techniques-perineales-utilisees-au-cours-de
2024
United Kingdom
review of literature
french abstract
workplace
occupation, nos
risks and benefits
lesion, nos
postpartum state, nos
occupational injuries
attentiveness
Technique Utilization
perineum, nos
risk assessment
postpartum period
---
https://www.cochrane.org/fr/CD016278/CENTRALED_quels-sont-les-benefices-et-les-risques-de-lacide-tranexamique-pour-prevenir-les-saignements
2024
United Kingdom
review of literature
french abstract
acid, nos
cesarean section, nos
risk assessment
tranexamic acid
hemorrhage, nos
risks and benefits
bloodletting
attentiveness
cesarean section
hemorrhage
birth, nos
parturition
---
https://www.cochrane.org/fr/CD012905/RENAL_quels-sont-les-benefices-et-les-risques-du-fenoldopam-pour-prevenir-ou-traiter-linsuffisance-renale
2024
United Kingdom
review of literature
french abstract
renal insufficiency, acute
acute renal failure syndrome, nos
risks and benefits
acute kidney injury
fenoldopam
risk assessment
attentiveness
---
https://www.cochrane.org/fr/CD016120/CENTRALED_quels-sont-les-benefices-et-les-risques-de-lutilisation-de-la-recuperation-du-sang-pendant-la
2024
United Kingdom
review of literature
french abstract
risks and benefits
blood
parturition
risk assessment
birth, nos
---
https://www.cochrane.org/fr/CD006982/CENTRALED_quels-sont-les-benefices-et-les-risques-de-la-lumiere-cyclique-en-unite-de-soins-intensifs-pour-les
2024
United Kingdom
review of literature
french abstract
infant, low birth weight
intensive care units
premature birth
immature
risk assessment
infant
light-for-dates without mention of fetal malnutrition
light
risks and benefits
light, nos
low birth weight
---
https://www.cochrane.org/fr/CD015333/ENT_quels-sont-les-benefices-et-les-risques-des-traitements-autres-que-medicamenteux-des-vertiges
2023
United Kingdom
review of literature
french abstract
postural vertigo, nos
drug, nos
Other treatments
risks and benefits
vertigo
drug therapy
Vertigo
risk assessment
---
https://www.cochrane.org/fr/CD001211/EYES_quels-sont-les-benefices-et-les-risques-des-antibiotiques-dans-le-traitement-de-la-conjonctivite
2023
United Kingdom
review of literature
french abstract
anti-bacterial agents
antibiotic, nos
conjunctivitis, bacterial
Antibiotics
risks and benefits
bacterium, nos
antibiotics
antibiotic therapy
risk assessment
acute conjunctivitis, nos
Conjunctivitis
---
https://www.cochrane.org/fr/CD013176/GUT_quels-sont-les-benefices-et-les-risques-de-lerythromycine-administree-avant-une-endoscopie-chez-les
2023
United Kingdom
review of literature
french abstract
administration
Administration
endoscopy, nos
erythromycin, nos
Endoscopy
hemorrhage, nos
risk assessment
erythromycin
risks and benefits
persons
intestines
hemorrhage
administrative personnel
administrators
intestinal tract, nos
endoscopy
bloodletting
---
https://www.cochrane.org/fr/CD014089/MUSKEL_quels-sont-les-benefices-et-les-risques-des-medicaments-qui-augmentent-le-flux-sanguin-vers-les
2023
United Kingdom
review of literature
french abstract
Ratio
secondary raynaud's phenomenon
Increased
Current Reformed Smoker, Years Unknown
increased vascular flow
risks and benefits
Fear Score 5
Medication
Placebo
raynaud disease
What Month is it
Loss of Chromosome 5
Intensity and Distress 5
drug, nos
Flow
Extremities
Clinical Status Ordinal Scale Outcome 5
extremities
Version
research report
ECOG Performance Status 5
anthelmintics
Severity of Symptom Score 5
No Flow
Thought Score 5
raynaud phenomenon
Death Related to Adverse Event
Agreement Score 5
Illness Intrusiveness Rating 5
Raynaud Phenomenon
Gleason Grade Group 5
risk assessment
placebos
Phase V Trial
Regulatory Report
Phosphodiesterase Inhibitor
Neck Pain Score 5
phosphodiesterase 5 inhibitors
Upset Score 5
albumin/globulin ratio
Increase
Flux
GDC Therapeutic Agent Terminology
---
https://www.cochrane.org/fr/CD013782/SYMPT_quels-sont-les-benefices-et-les-risques-de-lutilisation-de-corticosteroides-dans-le-traitement-de-la
2023
United Kingdom
review of literature
french abstract
risk assessment
neoplasms
fatigue
adrenal cortical hormone, nos
risks and benefits
cancer
neoplasm, malignant
Cancer
due to
adrenal cortex hormones
corticosteroid therapy
fatigue
---
https://www.cochrane.org/fr/CD013878/WOUNDS_quels-sont-les-benefices-et-les-risques-de-la-feuille-de-gel-de-silicone-pour-le-traitement-des
2023
United Kingdom
review of literature
french abstract
keloid
risk assessment
Cheloid
silicone
freezing
toilet facilities
leaves, nos
keloid
silicone gels
risks and benefits
---
https://www.cochrane.org/fr/CD014816/MUSKEL_quels-sont-les-benefices-et-les-risques-de-lexercice-physique-pour-les-personnes-atteintes-de-lupus
2023
United Kingdom
review of literature
french abstract
risks and benefits
risk assessment
physical exercise, nos
exercise
Dissemination
systemic lupus erythematosus
Physics
disease
persons
lupus erythematosus, systemic
Systemic lupus erythematosus
---
https://www.cochrane.org/fr/CD012974/SKIN_quels-sont-les-benefices-et-les-risques-du-traitement-neoadjuvant-traitement-medicamenteux-avant
2023
United Kingdom
review of literature
french abstract
kidnapping
risks and benefits
skin neoplasms
Tumors
malignant neoplasm of skin
neoplasms
Skin cancer
Tumors
Tumors
cancer of skin
Tumors
drug therapy
neoplasm, malignant
Tumors
Tumors
operative procedure, nos
Tumors
Tumors
Tumors
Tumors
Tumors
procedural approach, nos
surgical procedures, operative
drug, nos
Melanoma
crime
Tumors
risk assessment
melanoma
melanoma, cutaneous malignant
neoadjuvant therapy
---
https://www.cochrane.org/fr/CD012358/LIVER_quels-sont-les-benefices-et-les-risques-des-stents-recouverts-par-rapport-aux-stents-nus
2023
United Kingdom
review of literature
french abstract
Intrahepatic Route of Administration
risks and benefits
cirrhosis of liver, nos
persons
albumin/globulin ratio
Macau
What Month is it
systemic administration
Cirrhosis
Shunt
Systemic Immunotherapy
People
liver cirrhosis
research report
Recovered from Adverse Event
risk assessment
Shunt Device
stents
Stent Device
Hazard Ratio
disease
shunt, nos
---
https://www.cochrane.org/fr/CD015477/EMERG_quels-sont-les-benefices-et-les-risques-des-vaccins-dans-la-prevention-de-la-covid-19
2022
United Kingdom
review of literature
french abstract
COVID-19
vaccination, nos
vaccinia, nos
COVID-19 Vaccines
risks and benefits
vaccine, nos
Vaccins
vaccination
preventive immunization/medication
risk assessment
vaccines
Vaccinia
---
https://dumas.ccsd.cnrs.fr/dumas-03880511
2022
France
dissertations, academic
classification
laxative, nos
constipation
risks and benefits
osmosis, nos
laxatives
Systematic Review
constipation
risk assessment
review literature as topic
Systematics
Taxonomy
Literature
constipation
Systematics
Constipation
Systematics
---
https://www.cochrane.org/fr/CD015070/EYES_quels-sont-les-benefices-et-les-risques-des-corticoides-topiques-dans-le-traitement-du-syndrome-de
2022
United Kingdom
review of literature
french abstract
glucocorticoids
risk assessment
Eye
risks and benefits
adrenal cortical hormone, nos
corticosteroid therapy
eye
Eye
---
https://minerva-ebp.be/FR/Article/2273
2022
Belgium
critical appraisal or critical reading
telephone switchboard operator
risk assessment
risks and benefits
asthenia
atrial fibrillation
due to
anticoagulants
leadership
atrial fibrillation
has patient
warfarin
patients
anticoagulant, nos
disease
warfarin
reference standards
guideline
Atrial fibrillation
oral anticoagulants
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1138
2021
France
public health guidelines
Electronic Nicotine Delivery Systems
risk assessment
electron
risks and benefits
judgment
relative risk
Electronics
Electronic Cigarettes
---
https://www.cochrane.org/fr/CD013870/SKIN_quels-sont-les-benefices-et-les-risques-de-la-luminotherapie-dans-le-traitement-de-leczema-atopique
2021
United Kingdom
review of literature
french abstract
risk assessment
atopic dermatitis, nos
dermatitis, nos
dermatitis
phototherapy
dermatitis, atopic
naming, nos
risks and benefits
Atopic dermatitis
Eczema
---
https://www.cochrane.org/fr/CD012565/VASC_benefices-et-risques-des-beta-bloquants-par-rapport-au-placebo-ou-labsence-dintervention-dans-la
2021
United Kingdom
review of literature
french abstract
acute myocardial infarction
acute myocardial infarction, nos
Myocardial infarction
placebos
risk assessment
myocardial infarction
risks and benefits
beta, nos
research report
adrenergic beta-antagonists
obstruction, nos
albumin/globulin ratio
---
https://www.cochrane.org/fr/CD012039/HTN_quels-sont-les-principaux-benefices-et-risques-des-medicaments-destines-reduire-la-pression
2021
United Kingdom
review of literature
french abstract
pharmaceutical preparations
blood pressure, nos
causation
myocardium
Artery
emigration and immigration
persons
increased thickness
risks and benefits
drug, nos
myocardium, nos
Muscle
arterial pressure
muscles
causality
risk assessment
---
https://www.cochrane.org/fr/CD013761/WOUNDS_quels-sont-les-benefices-et-les-risques-des-lits-matelas-et-surmatelas-dans-la-prevention-et-le
2021
United Kingdom
review of literature
french abstract
eschar
bedding and linens
mattresses
preventive treatment, nos
beds
risk assessment
Sore
risks and benefits
pressure ulcer
---
https://www.cochrane.org/fr/CD013484/EYES_quels-sont-les-benefices-et-les-risques-du-tocilizumab-un-medicament-qui-reduit-linflammation-dans
2021
United Kingdom
review of literature
french abstract
tocilizumab
risk assessment
Diseases
risks and benefits
tocilizumab
disease, nos
Arteritis
drug, nos
Blood vessel
giant cell arteritis
pharmaceutical preparations
Cell
inflammation
Inflammation
inflammation, nos
blood vessels
disease
Inflammation
giant cell arteritis
celiac disease
tocilizumab
---
https://www.cochrane.org/fr/CD009434/ORAL_quels-sont-les-benefices-et-les-risques-de-lutilisation-du-laser-dans-le-traitement-de
2021
United Kingdom
review of literature
french abstract
laser therapy
hypersensitivity
risks and benefits
pitta, nos
Hypersensitivity
sensitive dentin
toothache
laser
risk assessment
toothache
acute pain
---
https://www.cochrane.org/fr/CD013624/WOUNDS_quels-sont-les-benefices-et-les-risques-des-differents-types-de-lits-matelas-et-surmatelas-dans-le
2021
France
United Kingdom
review of literature
french abstract
risks and benefits
Sore
beds
bedding and linens
eschar
mattresses
pressure ulcer
risk assessment
---
https://www.cochrane.org/fr/CD013029/EYES_quels-sont-les-benefices-et-les-risques-de-la-luminotherapie-de-faible-intensite-photobiomodulation
2021
France
United Kingdom
review of literature
french abstract
phototherapy
risks and benefits
geographic atrophy
disease, nos
degeneration, nos
eye, nos
risk assessment
macular degeneration
asthenia
affect
age, nos
macule, nos
Age related macular degeneration
macular degeneration
affect
macular degeneration
---
https://www.cochrane.org/fr/CD013297/EYES_quels-sont-les-benefices-et-les-risques-de-la-chirurgie-pour-la-membrane-epiretinienne-une-affection
2021
false
false
false
France
United Kingdom
review of literature
french abstract
eye, nos
ophthalmologic surgical procedures
epiretinal membrane
operative procedure, nos
affect
disease, nos
risks and benefits
risk assessment
---
https://www.cochrane.org/fr/CD010804/SYMPT_quels-sont-les-benefices-et-les-risques-de-lexercice-chez-les-adultes-atteints-de-cancer-qui
2021
false
false
false
France
United Kingdom
review of literature
french abstract
risk assessment
anorexia
loss of appetite
risks and benefits
adulthood
cancer
adult
neoplasms
weight loss
appetite
decreased body weight
exercise
weight loss
neoplasm, malignant
disease
loss of appetite
---
https://www.cochrane.org/fr/CD013263/SYMPT_quels-sont-les-benefices-et-les-risques-dune-injection-unique-de-ketorolac-un-medicament-anti
2021
France
United Kingdom
review of literature
french abstract
pain
risks and benefits
Injection moulding
operative procedure, nos
analgesics
risk assessment
administration of therapeutic substance, nos
procedural approach, nos
injections
anti-inflammatory agents
inflammatory pain
ketorolac
surgical procedures, operative
pain
---
https://www.cochrane.org/fr/CD007478/SKIN_quels-sont-les-benefices-et-les-risques-des-differents-traitements-des-maladies-de-la-peau-chez-les
2021
France
United Kingdom
review of literature
french abstract
lupus erythematosus, systemic
affect
body parts
risks and benefits
risk assessment
disease, nos
Dissemination
Systemic lupus erythematosus
autoimmune diseases
affect, nos
Diseases
systemic lupus erythematosus
skin diseases
autoimmune disease, nos
persons
human body
disease of skin, nos
autoimmune diseases
---
https://sfpt-fr.org/faq-vaccins
2021
France
pneumonia, viral
coronavirus infections
popular works
vaccine, nos
vaccines
Vaccinia
Vaccins
vaccinia, nos
risks and benefits
vaccination
preventive immunization/medication
vaccination, nos
risk assessment
pandemics
viral vaccines
COVID-19
COVID-19 Vaccines
---
https://www.cochrane.org/fr/CD013264/SYMPT_quels-sont-les-benefices-et-les-risques-dune-injection-unique-dibuprofene-un-medicament-anti
2021
United Kingdom
review of literature
french abstract
Injection moulding
injections
adult
administration of therapeutic substance, nos
Adult
inflammatory pain
pain
ibuprofen
analgesics
anti-inflammatory agents
procedural approach, nos
surgical procedures, operative
ibuprofen
risk assessment
adulthood
risks and benefits
Adult
operative procedure, nos
---
https://www.medix.ch/media/faltblatt_psa_test_fr_290420_1.pdf
2020
Switzerland
patient education handout
risk assessment
Step Unit of Distance
dermatomyositis
Scaffold Attachment Factor B1
Prostate-Specific antigen
Pulmonary Artery Intimal Sarcoma
polysialic acid
STEPS to Enhance Physical Activity
Platelets Additive Solution
Periodic Acid Schiff Staining Method
Prostate Specific Antigen Measurement
SLC22A18 wt Allele
Premorbid Adjustment Scale
risks and benefits
systolic pressure
---
https://www.cochrane.org/fr/CD012568/ORAL_quels-sont-les-benefices-et-les-risques-lies-lutilisation-dantibiotiques-ainsi-quau-nettoyage-par-un
2020
France
United Kingdom
review of literature
french abstract
dental-oral procedure or service, nos
antibiotic, nos
Diseases
anti-bacterial agents
dental diseases
patient care
occupational diseases
risks and benefits
disease of teeth, nos
risk assessment
Occupational disease
Antibiotics
tooth diseases
dental care
antibiotics
stomatognathic diseases
---
https://www.cochrane.org/fr/CD010686/SYMPT_quels-sont-les-benefices-et-les-risques-lies-lutilisation-de-la-realite-virtuelle-dans-un-contexte
2020
France
United Kingdom
review of literature
french abstract
Child
risks and benefits
Child
Child Health
delivery of health care
child care
Virtual Reality
child, nos
health care
risk assessment
Child
Child
---
https://www.cochrane.org/fr/CD013627/ENT_quels-sont-les-benefices-et-les-risques-pour-les-personnes-atteintes-de-covid-19-utiliser-des-bains
2020
France
United Kingdom
coronavirus infections
pneumonia, viral
review of literature
french abstract
mouthwashes
microbicides
health personnel
anti-infective agents
risk assessment
nose, nos
due to
risks and benefits
nasal sprays
persons
persons
pandemics
COVID-19
---
https://www.cochrane.org/fr/CD007407/SYMPT_quels-sont-les-benefices-et-les-risques-des-therapies-psychologiques-pour-les-adultes-souffrant-de
2020
France
United Kingdom
review of literature
french abstract
psychotherapy
Adult
risks and benefits
Cancer
cancer of head
Psychology
Adult
head and neck neoplasms
psychology
therapy, nos
headache
adult
due to
pain, nos
Cancer Pain
headache, nos
adulthood
scapegoating
risk assessment
neoplasm, malignant
headache
pain
psychology
pain
---
http://www.sudoc.fr/241734614
2020
France
dissertations, academic
risks and benefits
risk assessment
Literature
nutrition, nos
review literature as topic
overnutrition
malnutrition
sucking
---
https://dumas.ccsd.cnrs.fr/dumas-02289896
2019
France
dissertations, academic
Literature
base, nos
Meta-Analysis
review literature as topic
tea
tea, nos
antiemetic, nos
risks and benefits
meta-analysis as topic
antiemetics
tetrahydrocortisone
risk assessment
meta-analysis
---
http://www.sudoc.fr/236745514
2019
France
dissertations, academic
risks and benefits
Literature
vegan
diet, vegetarian
risk assessment
deficiency state
review literature as topic
Diet, Vegan
hazardous substances
Practice
health
vegetarian diet, nos
---
https://dumas.ccsd.cnrs.fr/dumas-02481419
2019
France
dissertations, academic
France
Surveys and Questionnaires
Practice
France
risk assessment
risk-taking
risks and benefits
dancer
french
France
France
france
detective
---
https://boutique.liguecancer.ch/files/kls/webshop/PDFs/francais/feuille-d-information-traitement-hormonal-de-la-menopause-022450201111.pdf
2018
Switzerland
patient education handout
risk assessment
hormone, nos
risks and benefits
hormonotherapy
hormones
---
https://dumas.ccsd.cnrs.fr/dumas-01929853/document
2018
France
dissertations, academic
hormones
general practitioners
menopause, nos
hormonotherapy
estrogen replacement therapy
Physicians
general treatment, nos
menopause
risk
hormone substitute, nos
risks and benefits
hormones
menopause
risk assessment
---
https://www.anses.fr/fr/system/files/PHYTO2016SA0057.pdf
2018
false
false
false
France
French
scientific and technical information
methods
relative risk
risk assessment
french
wrestling
chemical method, nos
inlets
judgment
behavior, nos
intermediate
france
relative
culture
behavior
risks and benefits
protestantism
methods
risk
bays
---
https://vigilanses.mag.anses.fr/sites/default/files/VigilansesN1_compl%C3%A9mentsalimentairesetsportifs_1.pdf
2017
false
false
false
France
French
journal article
athletes
complement, nos
dietary supplements
uncertain
health
risks and benefits
hazardous substances
health
risk assessment
---
https://www.anses.fr/fr/content/compl%C3%A9ments-alimentaires-destin%C3%A9s-aux-sportifs-des-risques-pour-la-sant%C3%A9-pour-des-b%C3%A9n%C3%A9fices
https://www.anses.fr/fr/system/files/NUT2014SA0008Ra.pdf
2016
false
false
false
France
French
technical report
athletes
hazardous substances
health
dietary supplements
uncertain
risks and benefits
complement, nos
health
risk assessment
---
